Immunomodulation by probiotics and prebiotics in hepatocellular carcinoma

doi:10.4254/wjh.v14.i2.372

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 2

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5560)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series.

Item

Count

PDF

272

WORD

128

HTML

2776

Figures (1-4)

282

Sum=3458

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

195

Download

695

Sum=890

Publishing Process of This Article

Item

Count

Browse

345

Download

867

Sum=1212

Feb 27, 2022 (publication date) through May 16, 2024

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Hepatol. Feb 27, 2022; 14(2): 372-385
Published online Feb 27, 2022. doi: 10.4254/wjh.v14.i2.372

Full Size Figure Download Figure

Figure 2 Proposed mechanism of action of probiotics against hepatocellular carcinoma progression. HDAC: Histone deacetylase; SCFAs: Short-chain fatty acids.

Citation: Russo E, Fiorindi C, Giudici F, Amedei A. Immunomodulation by probiotics and prebiotics in hepatocellular carcinoma. World J Hepatol 2022; 14(2): 372-385
URL: https://www.wjgnet.com/1948-5182/full/v14/i2/372.htm
DOI: https://dx.doi.org/10.4254/wjh.v14.i2.372